1. Liu, Youyi, Tang, Yifei, Jiang, Hongliang, Jin, Cheng, Wu, Minchen. 2023. Exosome-Related FTCD Facilitates M1 Macrophage Polarization and Impacts the Prognosis of Hepatocellular Carcinoma. In Biomolecules, 14, . doi:10.3390/biom14010041. https://pubmed.ncbi.nlm.nih.gov/38254641/
2. Wang, Siying, Zhou, Yangyang, Yu, Ruobing, Qin, Wenxin, Jin, Haojie. 2023. Loss of hepatic FTCD promotes lipid accumulation and hepatocarcinogenesis by upregulating PPARγ and SREBP2. In JHEP reports : innovation in hepatology, 5, 100843. doi:10.1016/j.jhepr.2023.100843. https://pubmed.ncbi.nlm.nih.gov/37675273/
3. Fujita, Koji, Yamada, Mari, Morishita, Asahiro, Kobara, Hideki, Masaki, Tsutomu. 2024. Cabozantinib inhibits the growth of lenvatinib-resistant hepatoma cells restoring FTCD expression. In Biochemical pharmacology, 226, 116321. doi:10.1016/j.bcp.2024.116321. https://pubmed.ncbi.nlm.nih.gov/38815631/
4. Kaneko, Yayoi, Shimoda, Kyohei, Ayala, Rafael, Zhang, Xiaodong, Kondo, Hisao. 2021. p97 and p47 function in membrane tethering in cooperation with FTCD during mitotic Golgi reassembly. In The EMBO journal, 40, e105853. doi:10.15252/embj.2020105853. https://pubmed.ncbi.nlm.nih.gov/33555040/
智鼠故事 
